Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G OWEN

Showing results (681-690 of 908) with videos related to

Pageof 91
Sort By:
Plos One|March 14, 2012
Socio-economic position and type 2 diabetes risk factors: patterns in UK children of South Asian, black African-Caribbean and white European originClaudia Thomas, Claire M Nightingale, Angela S Donin, et al.
Leukemia & Lymphoma|July 16, 2005
Superior quality and duration of responses among patients with mantle-cell lymphoma treated with fludarabine and cyclophosphamide with or without rituximab compared with prior responses to CHOPD Wayne Thomas, Roger G Owen, Stephen A N Johnson, et al.
American Journal of Ophthalmology|April 11, 2015
Incidence of Late-Stage Age-Related Macular Degeneration in American Whites: Systematic Review and Meta-analysisAlicja R Rudnicka, Venediktos V Kapetanakis, Zakariya Jarrar, et al.
Mbio|March 27, 2020
Metagenomic Exploration of the Marine Sponge <i>Mycale hentscheli</i> Uncovers Multiple Polyketide-Producing Bacterial SymbiontsMathew A Storey, Sarah K Andreassend, Joe Bracegirdle, et al.
British Journal of Haematology|February 5, 1998
B-lymphocyte suppression in multiple myeloma is a reversible phenomenon specific to normal B-cell progenitors and plasma cell precursorsA C Rawstron, F E Davies, R G Owen, et al.
Nature Chemical Biology|November 23, 2023
Metagenomic domain substitution for the high-throughput modification of nonribosomal peptidesSarah R Messenger, Edward M R McGuinniety, Luke J Stevenson, et al.
Plos One|February 10, 2012
Travel to school and physical activity levels in 9-10 year-old UK children of different ethnic origin; Child Heart and Health Study in England (CHASE)Christopher G Owen, Claire M Nightingale, Alicja R Rudnicka, et al.
Molecular Pathology : MP|February 1, 1997
p53 gene mutations in multiple myelomaR G Owen, S A Davis, J Randerson, et al.
Annals of the New York Academy of Sciences|January 1, 1987
Signals transduced by gamma-aminobutyric acid in cultured central nervous system neurons and thyrotropin releasing hormone in clonal pituitary cellsJ L Barker, B Dufy, J W Harrington, et al.
Haematologica|October 18, 2006
CD52 expression patterns in myeloma and the applicability of alemtuzumab therapyAndy C Rawstron, Giles Laycock-Brown, Geoff Hale, et al.
Pageof 91

Showing results (681-690 of 908) with videos related to

Sort By:
Pageof 91
Plos One|March 14, 2012
Socio-economic position and type 2 diabetes risk factors: patterns in UK children of South Asian, black African-Caribbean and white European originClaudia Thomas, Claire M Nightingale, Angela S Donin, et al.
Leukemia & Lymphoma|July 16, 2005
Superior quality and duration of responses among patients with mantle-cell lymphoma treated with fludarabine and cyclophosphamide with or without rituximab compared with prior responses to CHOPD Wayne Thomas, Roger G Owen, Stephen A N Johnson, et al.
American Journal of Ophthalmology|April 11, 2015
Incidence of Late-Stage Age-Related Macular Degeneration in American Whites: Systematic Review and Meta-analysisAlicja R Rudnicka, Venediktos V Kapetanakis, Zakariya Jarrar, et al.
Mbio|March 27, 2020
Metagenomic Exploration of the Marine Sponge <i>Mycale hentscheli</i> Uncovers Multiple Polyketide-Producing Bacterial SymbiontsMathew A Storey, Sarah K Andreassend, Joe Bracegirdle, et al.
British Journal of Haematology|February 5, 1998
B-lymphocyte suppression in multiple myeloma is a reversible phenomenon specific to normal B-cell progenitors and plasma cell precursorsA C Rawstron, F E Davies, R G Owen, et al.
Nature Chemical Biology|November 23, 2023
Metagenomic domain substitution for the high-throughput modification of nonribosomal peptidesSarah R Messenger, Edward M R McGuinniety, Luke J Stevenson, et al.
Plos One|February 10, 2012
Travel to school and physical activity levels in 9-10 year-old UK children of different ethnic origin; Child Heart and Health Study in England (CHASE)Christopher G Owen, Claire M Nightingale, Alicja R Rudnicka, et al.
Molecular Pathology : MP|February 1, 1997
p53 gene mutations in multiple myelomaR G Owen, S A Davis, J Randerson, et al.
Annals of the New York Academy of Sciences|January 1, 1987
Signals transduced by gamma-aminobutyric acid in cultured central nervous system neurons and thyrotropin releasing hormone in clonal pituitary cellsJ L Barker, B Dufy, J W Harrington, et al.
Haematologica|October 18, 2006
CD52 expression patterns in myeloma and the applicability of alemtuzumab therapyAndy C Rawstron, Giles Laycock-Brown, Geoff Hale, et al.
Pageof 91